Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
OBJECTIVE This study was conducted to describe the incidence of diabetes following pancreatic disease, assess how these patients are classified by clinicians, and compare clinical characteristics with type 1 and type 2 diabetes. RESEARCH DESIGN AND METHODS Primary care records in England (n = 2,360,631) were searched for incident cases of adult-onset diabetes between 1 January 2005 and 31 March 2016. We examined demographics, diabetes classification, glycemic control, and insulin use in those with and without pancreatic disease (subcategorized into acute pancreatitis or chronic pancreatic disease) before diabetes diagnosis. Regression analysis was used to control for baseline potential risk factors for poor glycemic control (HbA1c ≥7% [53 mmol/mol]) and insulin requirement. RESULTS We identified 31,789 new diagnoses of adult-onset diabetes. Diabetes following pancreatic disease (2.59 [95% CI 2.38–2.81] per 100,000 person-years) was more common than type 1 diabetes (1.64 [1.47–1.82]; P < 0.001). The 559 cases of diabetes following pancreatic disease were mostly classified by clinicians as type 2 diabetes (87.8%) and uncommonly as diabetes of the exocrine pancreas (2.7%). Diabetes following pancreatic disease was diagnosed at a median age of 59 years and BMI of 29.2 kg/m2. Diabetes following pancreatic disease was associated with poor glycemic control (adjusted odds ratio, 1.7 [1.3–2.2]; P < 0.001) compared with type 2 diabetes. Insulin use within 5 years was 4.1% (3.8–4.4) with type 2 diabetes, 20.9% (14.6–28.9) with diabetes following acute pancreatitis, and 45.8% (34.2–57.9) with diabetes following chronic pancreatic disease. CONCLUSIONS Diabetes of the exocrine pancreas is frequently labeled type 2 diabetes but has worse glycemic control and a markedly greater requirement for insulin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A distinguishing feature is concurrent pancreatic exocrine insuf fi ciency (consider screening individuals with acute and chronic pancreatitis for exocrine pancreatic insuf fi ciency by measuring fecal elastase), pathological pancreatic imaging (endoscopic ultrasound, MRI, and computed tomography), and absence of type 1 diabetes -associated autoimmunity (116 -120).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [117]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181 · cited 1×
“diabetes without preceding pancreatic disease, diabetes after acute pancreatitis, and diabetes after chronic pancreatic disease (27).”
BackgroundRegression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · cited 1×
“We initially created Cox proportional hazards models to assess the hazard of progression to insulin; however, these failed proportional hazards testing (28,29).”
MethodInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066 · cited 1×
“control as HbA1c $7% (53 mmol/mol), according to the generic target of the American Diabetes Association and the European Association for the Study of Diabetes hyperglycemia guidelines (24).”
MethodThe Regression Analysis of Binary Sequences
Cox, D. R. (1958) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1958.tb00292.x · Cited by 2,813 · cited 1×
“We created logistic regression models for odds of poor glycemic control at 1 year and at 5 years (26).”
MethodType 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
Hart, P. A., Bellin, M. D., Andersen, D. K., Bradley, D., Cruz-Monserrate, Z., Forsmark, C. E., Goodarzi, M. O., Habtezion, A., Korc, M., Kudva, Y. C., et al. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30106-6 · Cited by 551
Natural Course in Chronic Pancreatitis
Lankisch, P. G., Löhr-Happe, A., Otto, J., & Creutzfeldt, W. (1993) · Digestion · doi:10.1159/000201029 · Cited by 452 · cited 1×
“This form of diabetes results when a process, such as inflammation, neoplasia, or surgical resection, disrupts the global architecture or physiology of the pancreas, often resulting in both exocrine and endocrine dysfunction (2,3).”
BackgroundNewly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis
Das, S. L. M., Singh, P. P., Phillips, A. R. J., Murphy, R., Windsor, J. A., & Petrov, M. S. (2014) · Gut · doi:10.1136/gutjnl-2013-305062 · Cited by 401 · cited 1×
“sulin if monitored beyond 5 years (17).”
Test of Significance for 2 × 2 Contingency Tables
Yates, F. (1984) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2981577 · Cited by 364
Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c)
Ewald, N., Kaufmann, C., Raspe, A., Kloer, H. U., Bretzel, R. G., & Hardt, P. D. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2260 · Cited by 306 · cited 3×
“(1) used diagnostic criteria, including the presence of both exocrinepancreaticdysfunctionandpathological pancreatic imaging, to retrospectively identify diabetes of the exocrine pancreas in their hospital’s inpatients”
BackgroundMethodInfluentialSharma, M., Nazareth, I., & Petersen, I. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010210 · Cited by 291
Pancreatogenic Diabetes: Special Considerations for Management
Cui, Y., & Andersen, D. K. (2011) · Pancreatology · doi:10.1159/000329188 · Cited by 256 · cited 1×
“Glucagon production from pancreatic a-cells is also diminished, which may explain the episodes of severe hypoglycemia that are reported in some patients (8,9).”
BackgroundRickels, M. R., Bellin, M., Toledo, F. G. S., Robertson, R. P., Andersen, D. K., Chari, S. T., Brand, R., Frulloni, L., Anderson, M. A., & Whitcomb, D. C. (2013) · Pancreatology · doi:10.1016/j.pan.2013.05.002 · Cited by 249
β-cell failure as a complication of diabetes
Chang-Chen, K. J., Mullur, R., & Bernal-Mizrachi, E. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9101-5 · Cited by 225
Correa, A., Hinton, W., McGovern, A., van Vlymen, J., Yonova, I., Jones, S., & de Lusignan, S. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011092 · Cited by 185
Self-citationSELECTION BIAS IN EPIDEMIOLOGIC STUDIES12
KLEINBAUM, D. G., MORGENSTERN, H., & KUPPER, L. L. (1981) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113113 · Cited by 151 · cited 1×
“This method can result in misclassification and selection bias (30).”
MethodDe Lusignan, S. (2005) · Journal of Innovation in Health Informatics · doi:10.14236/jhi.v13i1.580 · Cited by 133
Pendharkar, S. A., Mathew, J., & Petrov, M. S. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.12.010 · Cited by 125
Brunicardi, F. C. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3566 · Cited by 107 · cited 1×
“In addition, pancreatic polypeptide upregulates insulin receptor expression in the liver, and its loss can lead to hepatic insulin resistance (7), an important physiological difference between diabetes of the exocrine pancreas and type 1 diabetes.”
BackgroundDiabetic control after total pancreatectomy
Jethwa, P., Sodergren, M. H., Lala, A., Webber, J., Buckels, J. A. C., Bramhall, S. R., & Mirza, D. F. (2006) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.01.022 · Cited by 106 · cited 1×
“This is caused by b-cell dysfunction after pancreatic inflammation or by absolute b-cell loss (5,6).”
BackgroundDiabetes of the exocrine pancreas: American Diabetes Association-compliant lexicon
Petrov, M. S. (2017) · Pancreatology · doi:10.1016/j.pan.2017.06.007 · Cited by 101
Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21 st century
Trang, T., Chan, J., & Graham, D. Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11467 · Cited by 97
β-Cell Dysfunction in Chronic Pancreatitis
Sasikala, M., Talukdar, R., Kumar, P. P., Radhika, G., Rao, G. V., Pradeep, R., Subramanyam, C., & Reddy, D. N. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2086-7 · Cited by 92
Gillies, N. A., Pendharkar, S. A., Asrani, V. M., Mathew, J., Windsor, J. A., & Petrov, M. S. (2016) · Pancreatology · doi:10.1016/j.pan.2016.06.661 · Cited by 87
Pendharkar, S. A., Asrani, V. M., Xiao, A., Yoon, H. D., Murphy, R., Windsor, J. A., & Petrov, M. S. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00074.2016 · Cited by 73
The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis
Duggan, S. N., Ewald, N., Kelleher, L., Griffin, O. M., Gibney, J., & Conlon, K. C. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.127 · Cited by 71
Klapdor, S., Richter, E. A., & Klapdor, R. (2012) · PubMed · Cited by 57
Surveillance of influenza-like illness in England and Wales during 1966-2006
Elliot, A. J., & Fleming, D. M. (2006) · Eurosurveillance · doi:10.2807/esm.11.10.00651-en · Cited by 51 · cited 1×
“RSC was initially established in 1964 for surveillance of influenza and respiratory infections (21) but has since expanded its scope to allow more detailed research.”
BackgroundEndocrine pancreatic function in patients after acute pancreatitis.
Malecka-Panas, E. I., Gąsiorowska, A., Kropiwnicka, A., Zlobinska, A., & Drzewoski, J. (2002) · PubMed · Cited by 49
Diabetic retinopathy in chronic pancreatitis
Gullo, L., PARENTI, M. A., Monti, L., Pezzilli, R., & Barbara, L. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91093-l · Cited by 47 · cited 1×
“of the exocrine pancreas, the risk of microvascular disease is as high as with type 1 diabetes (14).”
BackgroundPendharkar, S. A., Mathew, J., Zhao, J., Windsor, J. A., Exeter, D. J., & Petrov, M. S. (2017) · PubMed · Cited by 42
Knop, F. K., Vilsbøll, T., Larsen, S., Madsbad, S., Holst, J. J., & Krarup, T. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.05.011 · Cited by 31 · cited 1×
“Glucagon production from pancreatic a-cells is also diminished, which may explain the episodes of severe hypoglycemia that are reported in some patients (8,9).”
BackgroundIncorporating Incretin-Based Therapies into Clinical Practice for Patients with Type 2 Diabetes
Tibaldi, J. M. (2014) · Advances in Therapy · doi:10.1007/s12325-014-0100-5 · Cited by 14 · cited 1×
“Newer incretin-based agents, such as glucagon-like peptide 1 receptor agonists (“incretins”) and dipeptidyl peptidase 4 inhibitors (“gliptins”), would usually be considered contraindicated because of the presence of pancreatic damage (10).”
BackgroundGlucose tolerance and secretion of insulin in chronic pancreatitis.
Perušičová, J. (1989) · PubMed · Cited by 7
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
Metadata
- Authors
- Woodmansey, C., McGovern, A. P., McCullough, K. A., Whyte, M. B., Munro, N. M., Correa, A. C., Gatenby, P. A. C., Jones, S. A., & de Lusignan, S.
- Affiliations
- University of Surrey (GB)
- Royal Surrey County Hospital (GB)
- Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-08-31
- Volume
- 40
- Issue
- 11
- Pages
- 1486-1493
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2752023293
- Cited by
- 280
- References
- 36
- Citations by year
- 2026: 26 · 2025: 28 · 2024: 36 · 2023: 33 · 2022: 38 · 2021: 34 · 2020: 29 · 2019: 28 · 2018: 25 · 2017: 3
- FWCI
- 23.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Funders
- National Institute for Health and Care Research (ACF-2017-23-003)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 3c diabetes, type 2 diabetes, incidence, acute pancreatitis, chronic pancreatitis, glycemic control, insulin requirement, HbA1c, primary care records
- MeSH terms
- Acute Disease, Adult, Aged, Aged, 80 and over, Blood Glucose, Chronic Disease, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, England, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hyperglycemia, Insulin, Male, Middle Aged, Pancreatitis, Primary Health Care, Retrospective Studies, Risk Factors, Body Mass Index, Incidence, Pancreas, Exocrine, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.